Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide.
- Published In:
- Journal of controlled release : official journal of the Controlled Release Society, 314, 102-115 (2019)
- Authors:
- Qiu, Yingshan, Man, Rico C H, Liao, Qiuying, Kung, Keshia L K, Chow, Michael Y T, Lam, Jenny K W
- Database ID:
- RPEP-04435
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04435APA
Qiu, Yingshan; Man, Rico C H; Liao, Qiuying; Kung, Keshia L K; Chow, Michael Y T; Lam, Jenny K W. (2019). Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide.. Journal of controlled release : official journal of the Controlled Release Society, 314, 102-115. https://doi.org/10.1016/j.jconrel.2019.10.026
MLA
Qiu, Yingshan, et al. "Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide.." Journal of controlled release : official journal of the Controlled Release Society, 2019. https://doi.org/10.1016/j.jconrel.2019.10.026
RethinkPeptides
RethinkPeptides Research Database. "Effective mRNA pulmonary delivery by dry powder formulation ..." RPEP-04435. Retrieved from https://rethinkpeptides.com/research/qiu-2019-effective-mrna-pulmonary-delivery
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.